SS
DNA icon

Sunbelt Securities’s Ginkgo Bioworks DNA Stock Holding History

Sunbelt Securities’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$215 Hold
35
– – ﹤0.01% 2493
2025
Q4 		$291 Hold
35
– – ﹤0.01% 2353
2025
Q3 		$510 Buy
+35
New +$419 ﹤0.01% 2216
2023
Q3 		– Sell
-25
Closed -$1.86K – 1777
2023
Q2 		$1.86K Hold
25
– – ﹤0.01% 1454
2023
Q1 		$1.23K Buy
+25
New +$1.58K ﹤0.01% 1472

Other funds holding DNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sunbelt Securities's DNA Position: Q1 2026 in Review

Sunbelt Securities held its Ginkgo Bioworks (DNA) position steady in Q1 2026 at 35 shares worth $215. The position accounts for ﹤0.01% of the portfolio, ranked #2493.

Sunbelt Securities first reported a position in DNA in Q1 2023 and has held it in 5 quarters since. The position peaked at $1.86K in Q2 2023. 174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

  • Sunbelt Securities held 35 shares of Ginkgo Bioworks worth $215 as of Q1 2026.
  • Sunbelt Securities left its Ginkgo Bioworks share count unchanged in Q1 2026.
  • Ginkgo Bioworks made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #2493 holding.
  • Sunbelt Securities first reported a position in Ginkgo Bioworks in Q1 2023 and has held it in 5 quarters since.
  • Sunbelt Securities's Ginkgo Bioworks position peaked at $1.86K in Q2 2023.
  • 174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.